The pharmaceutical industry is among the most heavily patent‑dependent sectors. On the one hand, new drug development is characterized by high investment, long cycles, and considerable risks. Without ...
Japan's IP High Court is advocating new rules on when patent term extensions for pharmaceuticals should be granted. Shintaro Yamada of Shiga International Patent Office explains what they mean in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results